Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,166.3
-55.2 (-1.72%)

 

  • STI Straits Times Index
    3,166.3
    -55.2 (-1.72%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,512.2
    -5.4 (-0.35%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    24,080.5
    -659.6 (-2.67%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,564.1
    -20.1 (-0.56%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    28,751.6
    -747.7 (-2.53%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,561.6
    -137.8 (-2.06%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 1,737.0M
  • Value: 1,744.7M
  • Rise: 72
  • Fall: 305
  • Unch: 381

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
HGH0.021-0.004
Sembcorp Marine0.084-0.001
Medtecs Intl0.400+0.110
Genting Sing0.795-0.035
ThaiBev0.695-0.020
QT Vascular0.006-0.002
Singtel2.440-0.030
Tritech0.022+0.001
Suntec Reit1.550-0.020
Hatten Land0.061-

World Indices

World Indices
Name Last Change
Nasdaq 15,491.7 -353.6
HSI 24,080.5 -659.6
HSCEI 8,576.1 -233.7
Jakarta 6,561.6 -137.8
Nikkei 225 28,751.6 -747.7
SSE Comp 3,564.1 -20.1
Shanghai A 3,735.3 -21.1
Shanghai B 281.0 -1.2
KOSPI 2,936.4 -43.8

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

QT Vascular QT VASCULAR LTD.
Quotes 10 Minutes Delayed. Updated at 26 Nov 2021 17:04
Last (SGD): 0.006 Change: -0.002 High: 0.007 Remarks: -
Change (%): -25.00 Low: 0.006

Company Background

The Group is engaged in the design, assembly and distribution of advanced therapeutic solutions for the minimally invasive treatment of complex vascular diseases. The Group collaborates with industry specialists and physicians who are key opinion leaders to develop and offer physicians and patients new and differentiated devices to improve outcomes in complex peripheral and coronary interventions.

Click to show Stock Prices chart

Key Statistics

EPS (SGD) a -0.00442 Trailing EPS (SGD) b -0.00212 NAV (SGD) c -0.0003
PE a - Trailing PE d - Price / NAV c -20.0000
Dividend Yield (%) e - Cash In Hand (SGD) f 0.0001 Issued & Paid-up Shares g 2,268,306,000
Piotroski F Score 2 Market Cap (M) 13.610 Free Float (%) 85.3
Return on Equity (ROE) (%) h n.m. Revenue Growth (%) TTM i -92.097
Net Earnings Growth (%) j 59.301 Net Debt/Equity k n.a.
Under CPF Investment Scheme (CPFIS) No
Sector & Industry Manufacturing - Drugstore Chains
Category Classification Medical & Biotechnology
Index Components FTSE ST Catalist Index
Notes:
  1. Based on latest Full Year results announcement, adjusted based on Profit Attributable To Shareholders.
  2. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  3. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  4. Based on latest Full Year results announcement, adjusted for the current number of shares.
  5. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  6. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  7. Rounded to the nearest thousand. The figure pertains to the respective exchange the stock is listed on. Updated on 22 Nov 2021. Please click here for more information.
  8. Calculated based on Net Earnings / (Shareholders' Equity - Other Share Capital)
  9. Calculated based on (Current Year Revenue - Last Year Revenue) / Last Year Revenue
  10. Calculated based on (Current Year Earnings - Last Year Earnings) / Last Year Earnings
  11. Calculated based on (Long Term Debt + Short Term Debt - Cash and Short Term Investments)/(Shareholders' Equity - Other Share Capital)

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days --0.003
-33.33 %
10 Days --0.005
-45.45 %
20 Days --0.002
-25.00 %
Medium Term Return 3 Months -+0.001
+20.00 %
6 Months --0.001
-14.29 %
1 Year --0.001
-14.29 %
Long Term Return 2 Years -+0.003
+100.00 %
3 Years --0.003
-33.33 %
5 Years --0.100
-94.34 %
Annualised Return Annualised --
-43.69 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference QT Vascular SGX 13.610 - - -20.0000 -
Industry Drugstore Chains SGX 13.610 0.222 - 11.2310 -
Medical & Biotechnology SGX 1,032.866 19.080 16.207 1.4494 1.895
Index FTSE ST Catalist Index SGX 61.325 27.430 20.781 1.4014 1.931
Global Peer CVS HEALTH CORPORATION NYSE 120,811.891 16.829 15.945 1.6258 2.169
Global Peer WALGREENS BOOTS ALLIANCE INC NASDAQ 39,731.591 17.897 17.897 1.6966 4.117
Global Peer PING AN HEALTHCARE & TECHNO CO LTD HKEx 34,877.616 - - 1.9336 -
Global Peer RITE AID CORP NYSE 690.449 - - 1.3665 -
Global Peer PETMED EXPRESS INC NASDAQ 608.601 19.887 24.151 4.3017 3.930
Global Peer BEST & LESS GROUP HOLDINGS LTD ASX 382.369 4.707 4.707 8.8663 -
Global Peer 111 INC ADS EACH REP 2 ORD SHS CL A NASDAQ 193.118 - - 9.5348 -
Global Peer BIMI INTERNATIONAL MEDICAL INC NASDAQ 33.093 - - 0.9584 -
Global Peer CHINA JO-JO DRUGSTORES INC NASDAQ 22.638 - - 0.8793 -
Global Peer MEDILAND PHARM LTD ASX 23.145 - - 7.6289 -
Other Global Peers UNIVERSAL HEALTH INTL GP HLDG LTD (HKEx)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

More Information Available

More information is available to our subscribers, including:

  • Consensus Estimates
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.